DE69130457D1 - Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik - Google Patents

Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik

Info

Publication number
DE69130457D1
DE69130457D1 DE69130457T DE69130457T DE69130457D1 DE 69130457 D1 DE69130457 D1 DE 69130457D1 DE 69130457 T DE69130457 T DE 69130457T DE 69130457 T DE69130457 T DE 69130457T DE 69130457 D1 DE69130457 D1 DE 69130457D1
Authority
DE
Germany
Prior art keywords
protein
peptide
virus
fragments
fiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130457T
Other languages
English (en)
Other versions
DE69130457T2 (de
Inventor
Alexandre Avrameas
Jean Guillet
Anne Moraillon
Arthur Strosberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE69130457D1 publication Critical patent/DE69130457D1/de
Application granted granted Critical
Publication of DE69130457T2 publication Critical patent/DE69130457T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69130457T 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik Expired - Lifetime DE69130457T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9014519A FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
PCT/FR1991/000917 WO1992009632A1 (fr) 1990-11-21 1991-11-20 Fragments de la proteine env du virus de l'immunodeficience feline, anticorps et leurs applications dans le diagnostic

Publications (2)

Publication Number Publication Date
DE69130457D1 true DE69130457D1 (de) 1998-12-10
DE69130457T2 DE69130457T2 (de) 1999-05-27

Family

ID=9402430

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130457T Expired - Lifetime DE69130457T2 (de) 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik

Country Status (5)

Country Link
EP (1) EP0564477B1 (de)
AT (1) ATE172983T1 (de)
DE (1) DE69130457T2 (de)
FR (1) FR2669338A1 (de)
WO (1) WO1992009632A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0602046B2 (de) * 1991-06-14 2007-02-21 IDEXX Laboratories Inc Detektion des immunschwäche-virus aus felis
FR2692269B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
DE69333636T2 (de) * 1992-06-16 2005-10-06 Centre National De La Recherche Scientifique Nukleotid- und Peptidsequenzen des Immunschwächevirus der Katze, Isolat WO und Anwendungen der Sequenzen in der Diagnostik und zur Verhinderung der Infektion
FR2692270A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
FR2692279B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
GB9215232D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
WO1994020622A1 (en) * 1993-03-11 1994-09-15 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
FR2769916B1 (fr) * 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
AU2005267607B8 (en) 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
ATE435425T1 (de) 2003-09-11 2009-07-15 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus
WO2005062053A2 (en) 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2556141A1 (en) 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2576930C (en) 2004-06-30 2011-06-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
WO1990013573A1 (en) * 1989-05-08 1990-11-15 Idexx Corporation Polypeptides of feline t-cell lymphotropic lentivirus

Also Published As

Publication number Publication date
FR2669338B1 (de) 1995-03-03
WO1992009632A1 (fr) 1992-06-11
EP0564477A1 (de) 1993-10-13
FR2669338A1 (fr) 1992-05-22
ATE172983T1 (de) 1998-11-15
DE69130457T2 (de) 1999-05-27
EP0564477B1 (de) 1998-11-04

Similar Documents

Publication Publication Date Title
DE69130457D1 (de) Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik
Porter Chemical structure of γ-globulin and antibodies
CA2099976A1 (en) Repressors of the trans-activating function of papillomavirus e2 proteins
EP1475442A3 (de) Lymphotropische Polypeptide von dem Lentivirus von den T-zellen der Katze
DE69333802T8 (de) Äusseres membranprotein von haemophilus
ES2099066T3 (es) Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1).
DE69117949D1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
EP0175360A3 (de) Antikörper gegen Petide und ihre Verwendung zum Nachweis von Onkogene-Produkten
DE68928834T2 (de) Monoklonale antikörper gegen katzen-t-lymphotropes lentivirus
ATE132197T1 (de) Monoklonale antikörper
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
WO1995011975A3 (en) Retroviral superantigens, superantigen peptides, and methods of use
DE69019190D1 (de) Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
EP0177814A3 (de) Antikörper gegen Peptide und ihre Verwendung zum Nachweis von Onkogene-Produkten
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
DE69311796D1 (de) Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen
EP0293827A3 (de) Probe für Leishmaniosis
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
DE69327167D1 (de) Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung
DE69017352D1 (de) An HIV relatierte Peptide.
DE69233673D1 (de) Protein S polypeptide und deren Verwendungen
ATE140233T1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
KR890003946A (ko) 인간 면역 결핍 비루스 타입1의 항원의 제조방법 및 진단 및 치료제로서의 이의 용도
TH13136EX (th) แอนติเจนของ hiv

Legal Events

Date Code Title Description
8364 No opposition during term of opposition